Selecta Biosciences to Participate in Cantor Virtual Global Healthcare Conference

Rhea-AI Summary

On September 21, 2021, Selecta Biosciences, a biotechnology firm utilizing its ImmTOR™ platform, announced its participation in the Cantor Virtual Global Healthcare Conference scheduled for September 27-30, 2021. The company's management will engage in a fireside chat and hold one-on-one investor meetings, with the presentation set for September 27 at 3:20 p.m. EST. An archived webcast will be available on their website following the event. Selecta focuses on developing therapies that mitigate immune responses, with programs targeting gene and autoimmune diseases.

WATERTOWN, Mass., Sept. 21, 2021 (GLOBE NEWSWIRE) -- Selecta Biosciences, Inc. (NASDAQ: SELB), a biotechnology company leveraging its clinically validated ImmTOR™ platform to develop tolerogenic therapies that selectively mitigate unwanted immune responses, today announced that Company’s Management will participate in a fireside chat and one-on-one investor meetings at the Cantor Virtual Global Healthcare Conference to be held September 27-30, 2021.

Details on the conference be found below.

Cantor Virtual Global Healthcare Conference
Format: Fireside chat and one-on-one investor meetings
Date: Monday September 27, 2021
Presentation Time: 3:20 p.m. EST
Webcast: Click Here

An archived webcast will also be accessible in the Investors & Media section of the company’s website at www.selectabio.com.

About Selecta Biosciences, Inc.
Selecta Biosciences Inc. (NASDAQ: SELB) is a clinical stage biotechnology company leveraging its ImmTOR™ platform to develop tolerogenic therapies that selectively mitigate unwanted immune responses. With a proven ability to induce tolerance to highly immunogenic proteins, ImmTOR has the potential to amplify the efficacy of biologic therapies, including redosing of life-saving gene therapies, as well as restore the body’s natural self-tolerance in autoimmune diseases. Selecta has several proprietary and partnered programs in its pipeline focused on enzyme therapies, gene therapies, and autoimmune diseases. Selecta Biosciences is headquartered in the Greater Boston area. For more information, please visit www.selectabio.com.

For Investors:
Bruce Mackle
LifeSci Advisors, LLC
+1-929-469-3859
bmackle@lifesciadvisors.com

For Media: 
Brittany Leigh, Ph.D.
LifeSci Communications, LLC
+1-646-751-4366
bleigh@lifescicomms.com 

FAQ

What is Selecta Biosciences' participation in the Cantor Virtual Global Healthcare Conference?

Selecta Biosciences will participate in a fireside chat and one-on-one investor meetings at the Cantor Virtual Global Healthcare Conference from September 27-30, 2021.

When is Selecta Biosciences' presentation time at the conference?

Selecta Biosciences is scheduled to present on September 27, 2021, at 3:20 p.m. EST.

Where can I access the archived webcast of Selecta Biosciences' conference presentation?

The archived webcast will be available in the Investors & Media section of Selecta Biosciences' website after the event.

What is the focus of Selecta Biosciences' ImmTOR™ platform?

Selecta Biosciences' ImmTOR™ platform is designed to develop therapies that selectively mitigate unwanted immune responses, enhancing the efficacy of biologics and addressing autoimmune diseases.

What are the dates of the Cantor Virtual Global Healthcare Conference?

The Cantor Virtual Global Healthcare Conference will take place from September 27 to September 30, 2021.